Efficacy and Safety of Radiofrequency-Based Renal Denervation on Resistant Hypertensive Patients: A Systematic Review and Meta-analysis
LER Sobreira, FB Bezerra, VKT Sano… - High Blood Pressure & …, 2024 - Springer
Introduction New therapies for resistant hypertension (RH), including renal denervation
(RDN), have been studied. Aim Access the safety and effectiveness of radiofrequency-based …
(RDN), have been studied. Aim Access the safety and effectiveness of radiofrequency-based …
Renal denervation trials in hypertension–what we wait for in 2023/2024
F Mahfoud, M Kunz, F Götzinger - European Journal of Internal …, 2023 - ejinme.com
Arterial hypertension is the most frequent modifiable cardiovascular risk factor and remains
a leading cause of premature death worldwide with increasing prevalence [1] …
a leading cause of premature death worldwide with increasing prevalence [1] …
Interaction of afferent renal nerve activity and IL-1R signaling in hypertension
DC Baumann - 2024 - search.proquest.com
Renal denervation was recently approved by the FDA for the treatment of hypertension, but
the mechanism by which it reduces blood pressure is unclear. Studies of patients who have …
the mechanism by which it reduces blood pressure is unclear. Studies of patients who have …
[PDF][PDF] Invasive Assessment of Angina with No Obstructive Coronary Artery Disease
S Kunnirickal - valleyhealth.com
Invasive Assessment of Angina with No Obstructive Coronary Artery Disease Page 1 Invasive
Assessment of Angina with No Obstructive Coronary Artery Disease Steffne Kunnirickal, MD …
Assessment of Angina with No Obstructive Coronary Artery Disease Steffne Kunnirickal, MD …